Filing Details
- Accession Number:
- 0001237899-20-000038
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-31 16:36:38
- Reporting Period:
- 2020-08-31
- Accepted Time:
- 2020-08-31 16:36:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225471 | L George Sing | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-08-31 | 3,600 | $610.45 | 60,815 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-31 | 1,400 | $611.38 | 59,415 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-31 | 2,000 | $612.27 | 57,415 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-31 | 1,100 | $613.54 | 56,315 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-08-31 | 1,900 | $614.51 | 54,415 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,150 | Indirect | by Spouse |
Common Stock | 400 | Indirect | by Spouse/Cust Son |
Common Stock | 3,700 | Indirect | by Trust for Son |
Footnotes
- Represents volume-weighted average price of sales of 3,600 shares of Company stock on August 31, 2020 at prices ranging from $610.05 to $610.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
- Represents volume-weighted average price of sales of 1,400 shares of Company stock on August 31, 2020 at prices ranging from $611.13 to $611.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
- Represents volume-weighted average price of sales of 2,000 shares of Company stock on August 31, 2020 at prices ranging from $612.05 to $612.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
- Represents volume-weighted average price of sales of 1,100 shares of Company stock on August 31, 2020 at prices ranging from $613.00 to $613.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.
- Represents volume-weighted average price of sales of 1,900 shares of Company stock on August 31, 2020 at prices ranging from $614.01 to $614.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 31, 2020 at each separate price.